[1] |
Yoshimura M, Nao T, Miura T, et al. New quantitative method to diagnose coronary in-stent restenosis by 64-multislice computed tomography[J]. J Cardiol, 2015, 65(1):57-62.DOI: 10.1016/j.jjcc.2014.03.013.
|
[2] |
Jensen LO, Vikman S, Antonsen L,et al.Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation.The nordic intravascular ultrasound study (NIVUS)[J]. Cardiovasc Revasc Med, 2017, 18(8):577-582.DOI: 10.1016/j.carrev.2017.05.010.
|
[3] |
Aoki J, Tanabe K.Mechanisms of drug-eluting stent restenosis[J]. Cardiovasc Interv Ther, 2021, 36(1):23-29.DOI: 10.1007/s12928-020-00734-7.
|
[4] |
Shlofmitz E, Iantorno M, Waksman R.Restenosis of drug-eluting stents:a new classification system based on disease mechanism to guide treatment and state-of-the-art review[J]. Circ Cardiovasc Interv, 2019, 12(8):e007023.DOI: 10.1161/CIRCINTERVENTIONS.118.007023.
|
[5] |
|
[6] |
Nicolais C, Lakhter V, Virk H, et al. Therapeutic options for in-stent restenosis[J]. Curr Cardiol Rep, 2018, 20(2):7.DOI: 10.1007/s11886-018-0952-4.
|
[7] |
Ullrich H, Olschewski M, Münzel T,et al.Coronary in-stent restenosis:predictors and treatment[J]. Dtsch Arztebl Int, 2021, 118(38):637-644.DOI: 10.3238/arztebl.m2021.0254.
|
[8] |
Kumbhani DJ, Ingelmo CP, Schoenhagen P,et al.Meta-analysis of diagnostic efficacy of 64-slice computed tomography in the evaluation of coronary in-stent restenosis[J]. Am J Cardiol, 2009, 103(12):1675-1681.DOI: 10.1016/j.amjcard.2009.02.024.
|
[9] |
海丹丹,王玲,张焕莉.CT动脉造影诊断冠状动脉支架内部再狭窄的意义及临床护理[J].医学影像学杂志,2022,32(1):72-75.
|
[10] |
|
[11] |
Lettau M, Kotter E, Bendszus M,et al.Carotid artery stents on CT angiography:in vitro comparison of different stent designs and sizes using 16-,64- and 320-row CT scanners[J]. J Neuroradiol, 2014, 41(4):259-268.DOI: 10.1016/j.neurad.2013.10.003.
|
[12] |
Oba Y, Funayama H, Kario K.Usefulness of optical coherence tomography imaging for diagnosis of in-stent restenosis due to a stent fracture and morphological assessment[J]. Turk Kardiyol Dern Ars, 2019, 47(2):153.DOI: 10.5543/tkda.2018.57824.
|
[13] |
|
[14] |
|
[15] |
Steinvil A, Zhang YJ, Lee SY,et al.Intravascular ultrasound-guided drug-eluting stent implantation:an updated meta-analysis of randomized control trials and observational studies[J]. Int J Cardiol, 2016(216):133-139.DOI: 10.1016/j.ijcard.2016.04.154.
|
[16] |
Ha FJ, Giblett JP, Nerlekar N,et al.Optical coherence tomography guided percutaneous coronary intervention[J]. Heart Lung Circ, 2017, 26(12):1267-1276.DOI: 10.1016/j.hlc.2017.07.003.
|
[17] |
Kuku KO, Ekanem E, Azizi V,et al.Optical coherence tomography-guided percutaneous coronary intervention compared with other imaging guidance:a meta-analysis[J]. Int J Cardiovasc Imaging, 2018, 34(4):503-513.DOI: 10.1007/s10554-017-1272-2.
|
[18] |
|
[19] |
徐博,赵龙,张向阳.切割球囊和普通球囊治疗冠状动脉支架内再狭窄有效性和安全性的Meta分析[J].中国动脉硬化杂志,2014,22(3):298-303.
|
[20] |
|
[21] |
Galli S, Troiano S, Tespili M,et al.Results of paclitaxel-drug-coated balloons (Pantera Lux) for coronary in-stent restenosis:Italian experience from REGistry of Paclitaxel Eluting Balloon in ISR study[J]. J Cardiovasc Med (Hagerstown), 2021, 22(6):469-477.DOI: 10.2459/JCM.0000000000001127.
|
[22] |
Zheng YC, Lee WC, Fang HY,et al.Cutting balloon combined with drug-coated balloon angioplasty for the treatment of in-stent restenosis[J]. Int Heart J, 2021, 62(6):1213-1220.DOI: 10.1536/ihj.21-207.
|
[23] |
|
[24] |
Sato T, Tsuchida K, Yuasa S,et al.The effect of the debulking by excimer laser coronary angioplasty on long-term outcome compared with drug-coating balloon:insights from optical frequency domain imaging analysis[J]. Lasers Med Sci, 2020, 35(2):403-412.DOI: 10.1007/s10103-019-02833-1.
|
[25] |
Windecker S, Kolh P, Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)[J]. Eur Heart J, 2014, 35(37):2541-2619.DOI: 10.1093/eurheartj/ehu278.
|
[26] |
Alfonso F, Melgares R, Mainar V,et al.Therapeutic implications of in-stent restenosis located at the stent edge.Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial[J]. Eur Heart J, 2004, 25(20):1829-1835.DOI: 10.1016/j.ehj.2004.07.019.
|
[27] |
|
[28] |
Cui KY, Lyu SZ, Zhang M,et al.Drug-eluting balloon versus new-generation drug-eluting stent for the treatment of in-stent restenosis:an updated systematic review and meta-analysis[J]. Chin Med J (Engl), 2018, 131(5):600-607.DOI: 10.4103/0366-6999.226073.
|
[29] |
Giacoppo D, Alfonso F, Xu B,et al.Drug-Coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis[J]. J Am Coll Cardiol, 2020, 75(21):2664-2678.DOI: 10.1016/j.jacc.2020.04.006.
|